GeneDx Holdings Corp(:WGS) 
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and...
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | ||||||||||||||||||||||
diagnostic test revenue | 117,286,000 | 113,523,000 | 99,823,000 | 85,759,000 | 94,196,000 | 77,418,000 | 69,439,000 | 61,104,000 | 55,214,000 | 51,955,000 | 46,635,000 | 41,850,000 | 59,345,000 | 81,490,000 | 34,004,000 | 52,495,000 | 56,127,000 | 41,410,000 | ||||
other revenue | 3,703,000 | 3,220,000 | 2,869,000 | 1,356,000 | 1,444,000 | -544,000 | 1,075,000 | 1,318,000 | 2,204,000 | 1,348,000 | 2,071,000 | 1,289,000 | 2,005,000 | 1,744,000 | 2,165,000 | 1,446,000 | 1,674,000 | 1,768,000 | ||||
total revenue | 120,989,000 | 116,743,000 | 102,692,000 | 87,115,000 | 95,640,000 | 76,874,000 | 70,514,000 | 62,422,000 | 57,418,000 | 53,303,000 | 48,706,000 | 43,139,000 | 61,350,000 | 83,234,000 | 36,169,000 | 53,941,000 | 57,801,000 | 43,178,000 | ||||
yoy | 26.50% | 51.86% | 45.63% | 39.56% | 66.57% | 44.22% | 44.77% | 44.70% | -6.41% | -35.96% | 34.66% | -20.03% | 6.14% | 92.77% | ||||||||
qoq | 3.64% | 13.68% | 17.88% | -8.91% | 24.41% | 9.02% | 12.96% | 8.72% | 7.72% | 9.44% | 12.90% | -29.68% | -26.29% | 130.13% | -32.95% | -6.68% | 33.87% | |||||
cost of services | 36,721,000 | 32,216,000 | 31,790,000 | 28,639,000 | 29,435,000 | 29,045,000 | 27,562,000 | 25,011,000 | 26,664,000 | 28,044,000 | 29,949,000 | 27,903,000 | 77,676,000 | 69,685,000 | 65,767,000 | 48,316,000 | 48,602,000 | 58,752,000 | ||||
gross profit | 84,268,000 | 84,527,000 | 70,902,000 | 58,476,000 | 66,205,000 | 47,829,000 | 42,952,000 | 37,411,000 | 30,754,000 | 25,259,000 | 18,757,000 | 15,236,000 | -16,326,000 | 13,549,000 | -29,598,000 | 5,625,000 | 9,199,000 | -15,574,000 | ||||
yoy | 27.28% | 76.73% | 65.07% | 56.31% | 115.27% | 89.35% | 128.99% | 145.54% | -288.37% | 86.43% | -163.37% | 170.86% | -277.48% | -187.00% | ||||||||
qoq | -0.31% | 19.22% | 21.25% | -11.67% | 38.42% | 11.35% | 14.81% | 21.65% | 21.75% | 34.66% | 23.11% | -193.32% | -220.50% | -145.78% | -626.19% | -38.85% | -159.07% | |||||
gross margin % | 69.65% | 72.40% | 69.04% | 67.13% | 69.22% | 62.22% | 60.91% | 59.93% | 53.56% | 47.39% | 38.51% | 35.32% | -26.61% | 16.28% | -81.83% | 10.43% | 15.91% | -36.07% | NaN% | NaN% | NaN% | NaN% |
research and development | 24,541,000 | 19,829,000 | 15,079,000 | 12,577,000 | 11,588,000 | 11,665,000 | 10,902,000 | 11,567,000 | 12,248,000 | 14,288,000 | 17,138,000 | 14,592,000 | 24,366,000 | 13,354,000 | 27,168,000 | 21,315,000 | 22,246,000 | 17,831,000 | ||||
selling and marketing | 27,131,000 | 23,510,000 | 19,448,000 | 18,316,000 | 17,676,000 | 17,025,000 | 16,585,000 | 16,085,000 | 15,559,000 | 16,763,000 | 15,182,000 | 13,452,000 | 31,797,000 | 37,451,000 | 36,118,000 | 29,547,000 | 42,801,000 | 22,121,000 | ||||
general and administrative | 46,831,000 | 44,439,000 | 27,415,000 | 32,134,000 | 27,350,000 | 26,145,000 | 25,170,000 | 22,445,000 | 26,626,000 | 26,099,000 | 37,341,000 | 43,689,000 | 40,648,000 | 51,863,000 | 68,034,000 | 42,784,000 | 58,047,000 | 33,230,000 | ||||
income from operations | -14,235,000 | -3,251,000 | 8,960,000 | -4,551,000 | 8,806,000 | -7,780,000 | -10,579,000 | -13,660,000 | -25,643,000 | -42,967,000 | -51,622,000 | -60,364,000 | -324,882,000 | -90,816,000 | -162,649,000 | -89,305,000 | -116,022,000 | -89,603,000 | -1,277,960 | |||
yoy | -261.65% | -58.21% | -184.70% | -66.68% | -134.34% | -81.89% | -79.51% | -77.37% | -92.11% | -52.69% | -68.26% | -32.41% | 180.02% | 1.35% | 12627.24% | |||||||
qoq | 337.87% | -136.28% | -296.88% | -151.68% | -213.19% | -26.46% | -22.55% | -46.73% | -40.32% | -16.77% | -14.48% | -81.42% | 257.74% | -44.16% | 82.13% | -23.03% | 29.48% | 6911.41% | ||||
operating margin % | -11.77% | -2.78% | 8.73% | -5.22% | 9.21% | -10.12% | -15.00% | -21.88% | -44.66% | -80.61% | -105.99% | -139.93% | -529.56% | -109.11% | -449.69% | -165.56% | -200.73% | -207.52% | -Infinity% | NaN% | NaN% | NaN% |
non-operating (expenses) income | ||||||||||||||||||||||
change in fair value of financial liabilities | 1,116,000 | -3,401,000 | ||||||||||||||||||||
interest expense | -504,750 | -562,000 | -817,000 | -640,000 | -894,000 | -597,000 | -626,000 | -767,000 | -803,000 | -806,000 | -790,000 | -808,000 | -707,000 | -683,000 | ||||||||
other income | -4,591,000 | -174,000 | 239,000 | 209,000 | -714,000 | 1,144,000 | 37,000 | -49,000 | -1,134,000 | 86,000 | 2,716,000 | -1,000 | 2,000 | 56,000 | 50,000 | -520,000 | 14,287,840 | |||||
total non-operating expense | -1,016,250 | -4,137,000 | ||||||||||||||||||||
income before income taxes | -18,230,000 | -7,388,000 | 10,563,000 | -6,082,000 | 5,414,000 | -8,359,000 | -29,363,000 | -20,321,000 | -26,184,000 | -42,458,000 | -46,915,000 | -61,136,000 | -308,671,000 | -77,646,000 | -134,819,000 | -76,896,000 | -40,427,000 | 31,392,000 | 13,009,880 | |||
income tax benefit | 564,000 | -247,000 | 246,000 | -447,000 | 24,000 | 47,000 | 190,000 | 82,000 | 411,000 | 172,000 | 196,000 | 147,000 | -90,000 | 65,000 | 49,077,000 | |||||||
net income | -17,666,000 | -7,635,000 | 10,809,000 | -6,529,000 | 5,438,000 | -8,312,000 | -29,173,000 | -20,239,000 | 13,009,880 | |||||||||||||
yoy | -424.86% | -8.14% | -137.05% | -67.74% | ||||||||||||||||||
qoq | 131.38% | -170.64% | -265.55% | -220.06% | -165.42% | -71.51% | 44.14% | |||||||||||||||
net income margin % | -14.60% | -6.54% | 10.53% | -7.49% | 5.69% | -10.81% | -41.37% | -32.42% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | Infinity% | NaN% | NaN% | NaN% |
other comprehensive income, net of tax | ||||||||||||||||||||||
unrealized gain related to available for sale securities | -66,000 | 190,000 | -93,000 | 75,000 | -88,000 | 459,000 | 168,000 | |||||||||||||||
comprehensive loss | -17,732,000 | -7,445,000 | -6,454,000 | 5,350,000 | -7,853,000 | -29,005,000 | -20,373,000 | |||||||||||||||
weighted-average shares outstanding of class a common stock | 28,797,730,000 | 28,147,948,000 | 26,891,213,000 | 27,095,986,000 | 26,617,955,000 | 26,062,170,000 | 24,311,989,000 | 25,788,747,000 | 25,418,358,000 | 20,061,945,000 | 380,764,176,000 | 337,752,029,000 | 244,368,743,000 | |||||||||
basic and diluted loss per share, class a common stock | -0.03 | -0.27 | -0.23 | |||||||||||||||||||
non-operating income (expenses) | ||||||||||||||||||||||
change in fair value of warrants and contingent liabilities | 2,181,000 | |||||||||||||||||||||
total non-operating income | 1,603,000 | -3,392,000 | -579,000 | -18,784,000 | -541,000 | 509,000 | ||||||||||||||||
comprehensive income | 10,716,000 | |||||||||||||||||||||
weighted-average shares outstanding of class a common stock - basic | 28,579,704,000 | |||||||||||||||||||||
earnings per share, class a common stock- basic | 0.38 | |||||||||||||||||||||
weighted-average shares outstanding of class a common stock - diluted | 29,753,933 | |||||||||||||||||||||
earnings per share, class a common stock- diluted | 0.36 | |||||||||||||||||||||
change in fair value of warrants | -1,100,000 | |||||||||||||||||||||
total non-operating expenses | -1,531,000 | |||||||||||||||||||||
impairment loss | 8,282,000 | 2,120,000 | ||||||||||||||||||||
other operating expenses | 785,000 | 774,000 | 874,000 | 974,000 | 1,964,000 | 2,794,000 | ||||||||||||||||
change in fair value of warrants and earn-out contingent liabilities | -2,847,500 | -880,000 | -4,409,000 | -6,101,000 | ||||||||||||||||||
interest income | -698,000 | -843,000 | -978,000 | 1,053,000 | 1,700,000 | 732,000 | 1,136,000 | 996,000 | 382,000 | 27,000 | 22,000 | 27,000 | ||||||||||
other comprehensive loss, net of tax | ||||||||||||||||||||||
basic and diluted net loss per share, class a common stock | 0.23 | -0.31 | -1.1 | -0.78 | -0.92 | -1.64 | -1.84 | -3.04 | -0.25 | -0.31 | ||||||||||||
other expense | -13,481,000 | |||||||||||||||||||||
total non-operating loss | -6,661,000 | |||||||||||||||||||||
unrealized loss related to available for sale securities | -134,000 | |||||||||||||||||||||
change in fair market value of warrant and earn-out contingent liabilities | 486,000 | 590,000 | 3,547,000 | -3,453,000 | 15,879,000 | 12,978,000 | 28,182,000 | 13,190,000 | 76,230,000 | 122,171,000 | ||||||||||||
net loss and comprehensive loss | -37,498,500 | -42,286,000 | -46,719,000 | -60,989,000 | -85,742,000 | -76,896,000 | ||||||||||||||||
revenue: | ||||||||||||||||||||||
related party expenses | 1,052,000 | 1,747,000 | 1,600,000 | 1,697,000 | 1,731,000 | 1,284,000 | 2,127,000 | 847,000 | ||||||||||||||
other | -334,000 | |||||||||||||||||||||
other income, net: | ||||||||||||||||||||||
total other income | 4,707,000 | -772,000 | 16,211,000 | 13,170,000 | 27,830,000 | 12,409,000 | 75,595,000 | 120,995,000 | ||||||||||||||
net income and comprehensive income | -60,054,750 | -77,581,000 | -51,240,750 | 31,392,000 | ||||||||||||||||||
weighted-average shares outstanding of class a common stock for diluted earnings | 380,764,176,000 | 210,330,946,000 | ||||||||||||||||||||
basic net income per share, class a common stock | -0.188 | -0.2 | -0.813 | 0.17 | ||||||||||||||||||
diluted net income per share, class a common stock | -0.188 | -0.2 | -0.813 | 0.15 | ||||||||||||||||||
income tax provision | ||||||||||||||||||||||
weighted-average shares outstanding of class a common stock for basic earnings | 185,680,394,000 | |||||||||||||||||||||
general and administrative expenses | 1,277,960 | |||||||||||||||||||||
other income: | ||||||||||||||||||||||
change in fair value of warrant liabilities | 14,276,800 | |||||||||||||||||||||
interest earned on marketable securities held in trust account | 11,040 | |||||||||||||||||||||
weighted-average shares outstanding of class a redeemable common stock, basic and diluted | 44,275,000 | |||||||||||||||||||||
basic and diluted net income per share, class a redeemable common stock | ||||||||||||||||||||||
weighted-average shares outstanding of class b non-redeemable common stock, basic | 11,068,750 | |||||||||||||||||||||
basic net income per share, class b non-redeemable common stock | 1.18 | |||||||||||||||||||||
weighted-average shares outstanding of class a and b non-redeemable common stock, diluted | 13,621,590 | |||||||||||||||||||||
diluted net income per share, class a and b non-redeemable common stock | -0.09 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets: | ||||||||||||||||||||
current assets: | ||||||||||||||||||||
cash and cash equivalents | 104,997,000 | 95,968,000 | 74,120,000 | 99,704,000 | 85,212,000 | 57,894,000 | 56,076,000 | 83,673,000 | 99,681,000 | 87,387,000 | 123,933,000 | 123,933,000 | 123,933,000 | 191,360,000 | 284,647,000 | 315,002,000 | 400,569,000 | 461,276,000 | ||
marketable securities | 66,285,000 | 59,111,000 | 60,438,000 | 59,456,000 | 55,973,000 | 58,566,000 | 50,784,000 | 29,239,000 | 30,467,000 | 26,910,000 | ||||||||||
accounts receivable | 74,370,000 | 60,938,000 | 48,028,000 | 45,983,000 | 37,426,000 | 38,220,000 | 25,500,000 | 28,151,000 | 32,371,000 | 31,908,000 | 42,634,000 | 42,634,000 | 42,634,000 | 42,669,000 | 45,803,000 | 37,642,000 | 26,509,000 | 21,257,000 | ||
inventory | 13,951,000 | 10,569,000 | 11,932,000 | 12,662,000 | 10,650,000 | 10,770,000 | 10,322,000 | 11,615,000 | 8,777,000 | 9,349,000 | 13,665,000 | 13,665,000 | 13,665,000 | 44,173,000 | 41,601,000 | 36,318,000 | 33,456,000 | 31,174,000 | ||
prepaid expenses and other current assets | 8,685,000 | 10,997,000 | 10,319,000 | 8,011,000 | 8,504,000 | 20,300,000 | 18,792,000 | 9,974,000 | 10,598,000 | 15,761,000 | 18,212,000 | 18,212,000 | ||||||||
total current assets | 268,288,000 | 237,583,000 | 204,837,000 | 225,816,000 | 197,968,000 | 186,010,000 | 162,167,000 | 163,424,000 | 182,339,000 | 171,813,000 | 212,622,000 | 212,622,000 | 212,622,000 | 306,610,000 | 402,701,000 | 410,424,000 | 483,544,000 | 538,511,000 | 396,467 | 921,169 |
operating lease right-of-use assets | 23,412,000 | 24,200,000 | 24,978,000 | 24,883,000 | 25,613,000 | 24,936,000 | 25,624,000 | 26,304,000 | 26,900,000 | 27,536,000 | 32,758,000 | 32,758,000 | 32,758,000 | 44,033,000 | 44,038,000 | 38,417,000 | ||||
property and equipment | 45,693,000 | 42,422,000 | 40,120,000 | 36,383,000 | 32,893,000 | 31,452,000 | 31,339,000 | 31,301,000 | 32,479,000 | 35,746,000 | 51,527,000 | 51,527,000 | 51,527,000 | 84,369,000 | 89,455,000 | 60,976,000 | 62,719,000 | 60,333,000 | ||
goodwill | 13,520,000 | 12,798,000 | 12,926,000 | 181,468,000 | 181,184,000 | |||||||||||||||
intangible assets | 168,481,000 | 172,585,000 | 176,689,000 | 155,094,000 | 158,600,000 | 162,106,000 | 165,613,000 | 169,119,000 | 172,625,000 | 176,131,000 | 186,650,000 | 186,650,000 | 186,650,000 | 190,156,000 | 193,663,000 | |||||
other assets | 4,316,000 | 4,314,000 | 4,313,000 | 4,254,000 | 4,306,000 | 4,336,000 | 4,357,000 | 4,380,000 | 4,413,000 | 6,059,000 | 6,485,000 | 6,485,000 | 6,485,000 | 7,968,000 | 7,869,000 | 6,953,000 | 6,930,000 | 3,613,000 | ||
total assets | 523,710,000 | 493,902,000 | 463,863,000 | 446,430,000 | 419,380,000 | 408,840,000 | 389,100,000 | 394,528,000 | 418,756,000 | 417,285,000 | 490,942,000 | 490,942,000 | 490,942,000 | 828,974,000 | 933,280,000 | 517,670,000 | 554,093,000 | 603,357,000 | 443,182,377 | 443,696,039 |
liabilities and stockholders’ equity: | ||||||||||||||||||||
current liabilities: | ||||||||||||||||||||
accounts payable and accrued expenses | 57,645,000 | 50,334,000 | 49,239,000 | 41,862,000 | 30,044,000 | 56,416,000 | 51,959,000 | 32,410,000 | 37,456,000 | 38,873,000 | 84,878,000 | 84,878,000 | 86,884,000 | 115,878,000 | 68,880,000 | 43,079,000 | 2,244,995 | 1,491,735 | ||
short-term lease liabilities | 4,404,000 | 4,429,000 | 3,083,000 | 3,124,000 | 3,336,000 | 3,698,000 | 4,001,000 | 4,043,000 | 3,647,000 | 3,677,000 | 6,121,000 | 6,121,000 | 4,996,000 | 4,755,000 | 5,072,000 | |||||
other current liabilities | 46,859,000 | 32,858,000 | 19,084,000 | 24,555,000 | 19,830,000 | 16,501,000 | 11,097,000 | 13,240,000 | 16,336,000 | 21,846,000 | 49,705,000 | 49,705,000 | 49,665,000 | 68,623,000 | 81,619,000 | 23,384,000 | 29,968,000 | 26,369,000 | ||
total current liabilities | 108,908,000 | 87,621,000 | 71,406,000 | 69,541,000 | 54,817,000 | 77,342,000 | 68,270,000 | 50,734,000 | 58,818,000 | 68,366,000 | 144,297,000 | 144,297,000 | 144,297,000 | 162,331,000 | 204,606,000 | 100,639,000 | 101,284,000 | 71,366,000 | 2,244,995 | 1,491,735 |
long-term debt | 48,176,000 | 51,579,000 | 51,683,000 | 51,794,000 | 51,913,000 | 52,034,000 | 52,160,000 | 52,293,000 | 52,688,000 | 6,052,000 | 6,250,000 | 6,250,000 | 6,250,000 | 10,651,000 | 11,000,000 | 11,000,000 | 11,000,000 | 11,000,000 | ||
long-term lease liabilities | 56,046,000 | 57,153,000 | 59,619,000 | 59,918,000 | 60,919,000 | 60,369,000 | 60,800,000 | 62,030,000 | 62,938,000 | 63,889,000 | 60,013,000 | 60,013,000 | 60,013,000 | 62,336,000 | 62,806,000 | 57,478,000 | ||||
other liabilities | 1,641,000 | 4,258,000 | 3,275,000 | 6,619,000 | 5,519,000 | 13,540,000 | 12,660,000 | 20,836,000 | 14,735,000 | 22,660,000 | 22,000,000 | 22,000,000 | 22,000,000 | 20,200,000 | 500,000 | 500,000 | 3,480,000 | 21,699,000 | ||
deferred taxes | 757,000 | 1,033,000 | 747,000 | 1,153,000 | 965,000 | 1,054,000 | 1,167,000 | 1,418,000 | 1,560,000 | 2,060,000 | 2,659,000 | 2,659,000 | 2,659,000 | 2,603,000 | 2,668,000 | |||||
total liabilities | 215,528,000 | 201,644,000 | 186,730,000 | 189,025,000 | 174,133,000 | 204,339,000 | 195,057,000 | 187,311,000 | 190,739,000 | 163,027,000 | 237,237,000 | 237,237,000 | 237,237,000 | 267,680,000 | 296,006,000 | 188,226,000 | 165,990,000 | 212,094,000 | 130,424,545 | 143,948,085 |
purchase commitments and contingencies | ||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | ||||||||||||||||||||
class a common stock | 3,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 | 1,000 | 1,000 | 38,000 | 38,000 | 307,757,830 | 294,747,950 | ||||
additional paid-in capital | 1,680,738,000 | 1,647,083,000 | 1,624,513,000 | 1,615,501,000 | 1,596,889,000 | 1,561,493,000 | 1,543,182,000 | 1,527,351,000 | 1,527,778,000 | 1,528,671,000 | 1,378,125,000 | 1,378,125,000 | 1,378,088,000 | 1,376,916,000 | 1,375,315,000 | 981,757,000 | 90,367,188 | 103,376,938 | ||
accumulated deficit | -1,373,495,000 | -1,355,829,000 | -1,348,194,000 | -1,359,003,000 | -1,352,474,000 | -1,357,912,000 | -1,349,600,000 | -1,320,427,000 | -1,300,188,000 | -1,274,415,000 | -1,124,421,000 | -1,124,421,000 | -1,124,421,000 | -815,660,000 | -738,079,000 | -652,337,000 | -85,369,642 | -98,379,521 | ||
accumulated other comprehensive income | 936,000 | 1,002,000 | 812,000 | 905,000 | 830,000 | 918,000 | 459,000 | 291,000 | 425,000 | |||||||||||
total stockholders’ equity | 308,182,000 | 292,258,000 | 277,133,000 | 257,405,000 | 245,247,000 | 204,501,000 | 194,043,000 | 207,217,000 | 228,017,000 | 254,258,000 | 253,705,000 | 253,705,000 | 253,705,000 | 561,294,000 | 637,274,000 | 329,444,000 | 5,000,002 | 5,000,004 | ||
total liabilities and stockholders’ equity | 523,710,000 | 493,902,000 | 463,863,000 | 446,430,000 | 419,380,000 | 408,840,000 | 389,100,000 | 394,528,000 | 418,756,000 | 417,285,000 | 490,942,000 | 490,942,000 | 490,942,000 | 828,974,000 | 933,280,000 | 517,670,000 | 443,182,377 | 443,696,039 | ||
preferred stock, 0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at march 31, 2025 and december 31, 2024, respectively | ||||||||||||||||||||
assets | ||||||||||||||||||||
due from related parties | 203,000 | 260,000 | 693,000 | 772,000 | 445,000 | 498,000 | 708,000 | 708,000 | 708,000 | 1,194,000 | 1,110,000 | 125,000 | 54,000 | 413,000 | ||||||
liabilities and stockholders’ equity | ||||||||||||||||||||
due to related parties | 1,607,000 | 727,000 | 1,213,000 | 1,041,000 | 1,379,000 | 3,970,000 | 3,593,000 | 3,593,000 | 3,593,000 | 1,828,000 | 2,354,000 | 3,237,000 | 2,623,000 | 1,425,000 | ||||||
preferred stock, 0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at december 31, 2024 and december 31, 2023, respectively | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at september 30, 2024 and december 31, 2023 | ||||||||||||||||||||
commitments and contingencies | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at june 30, 2024 and december 31, 2023 | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 shares authorized, 0 shares issued and outstanding at march 31, 2024 and december 31, 2023 | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 shares authorized at december 31, 2023 and december 31, 2022; 0 shares issued and outstanding at december 31, 2023 and december 31, 2022, respectively | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 and 1,000,000 shares authorized at september 30, 2023 and december 31, 2022, respectively; 0 shares issued and outstanding at september 30, 2023 and december 31, 2022, respectively | ||||||||||||||||||||
restricted cash | 13,470,000 | 13,470,000 | 13,470,000 | 14,370,000 | 14,370,000 | 900,000 | 900,000 | 900,000 | ||||||||||||
long-term restricted cash | 900,000 | 900,000 | 900,000 | |||||||||||||||||
warrant liability | 418,000 | 418,000 | 418,000 | 5,059,000 | 7,258,000 | 15,177,000 | 21,555,000 | 46,629,000 | 112,683,300 | 126,960,100 | ||||||||||
earn-out contingent liability | 1,600,000 | 1,600,000 | 1,600,000 | 3,432,000 | 10,244,000 | 61,400,000 | ||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 and 1,000,000 shares authorized at june 30, 2023 and december 31, 2022, respectively; 0 shares issued and outstanding at june 30, 2023 and december 31, 2022, respectively | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 and 1,000,000 shares authorized at march 31, 2023 and december 31, 2022, respectively; 0 shares issued and outstanding at march 31, 2023 and december 31, 2022, respectively | ||||||||||||||||||||
prepaid expenses | 11,822,000 | 17,516,000 | 21,547,000 | 17,241,000 | 19,154,000 | 20,205,000 | 228,508 | 293,754 | ||||||||||||
other current assets | 6,390,000 | 9,698,000 | 7,993,000 | 4,096,000 | 3,802,000 | 4,186,000 | ||||||||||||||
accounts payable | 46,017,000 | 44,693,000 | ||||||||||||||||||
accrued expenses | 38,861,000 | 20,108,000 | ||||||||||||||||||
contract liabilities | 40,000 | 66,000 | 473,000 | |||||||||||||||||
current portion of lease liabilities | 6,121,000 | |||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 shares authorized at december 31, 2022 and december 31, 2021; 0 shares issued and outstanding at december 31, 2022 and december 31, 2021, respectively | ||||||||||||||||||||
earn-out contingent liabilities | 4,500,000 | 7,168,000 | ||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 and 0 shares authorized at september 30, 2022 and december 31, 2021, respectively; 0 shares issued and outstanding at september 30, 2022 and december 31, 2021, respectively | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 and 0 shares authorized at june 30, 2022 and december 31, 2021, respectively; 0 shares issued and outstanding at june 30, 2022 and december 31, 2021, respectively | ||||||||||||||||||||
class a common stock, 0.0001 par value... | 38,000 | 24,000 | 1,349 | 1,480 | ||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 and 0 shares authorized at march 31, 2022 and december 31, 2021, respectively; 0 shares issued and outstanding at march 31, 2022 and december 31, 2021, respectively | ||||||||||||||||||||
liabilities, redeemable convertible preferred stock and stockholders’ equity | ||||||||||||||||||||
current portion of capital lease obligations | 3,419,000 | |||||||||||||||||||
stock-based compensation liabilities | ||||||||||||||||||||
capital lease obligations, net of current portion | 18,427,000 | |||||||||||||||||||
redeemable convertible preferred stock | ||||||||||||||||||||
series a-1 redeemable convertible preferred stock, 0.00001 par value: 0 and 55,399,943 shares authorized, issued and outstanding at december 31, 2021 and december 31, 2020, respectively; aggregate liquidation preference of 0 and 55,000 at december 31, 2021 and december 31, 2020, respectively | ||||||||||||||||||||
series a-2 redeemable convertible preferred stock, 0.00001 par value: 0 and 64,718,940 shares authorized at december 31, 2021 and december 31, 2020, respectively; 0 and 49,700,364 shares authorized, issued and outstanding at december 31, 2021 and december 31, 2020, respectively; aggregate liquidation preference of 0 and 49,342 at december 31, 2021 and december 31, 2020, respectively | ||||||||||||||||||||
series b redeemable convertible preferred stock, 0.00001 par value: 0 and 41,937,960 shares authorized, issued and outstanding at december 31, 2021 and december 31, 2020, respectively; aggregate liquidation preference of 0 and 204,302 at december 31, 2021and december 31, 2020, respectively | ||||||||||||||||||||
series c redeemable convertible preferred stock, 0.00001 par value: 0 and 24,497,317 shares authorized at december 31, 2021 and december 31, 2020, respectively; 0 and 24,496,946 shares issued and outstanding at december 31, 2021 and december 31, 2020, respectively; aggregate liquidation preference of 0 and 121,397 at december 31, 2021 and december 31, 2020, respectively | ||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||
preferred stock, 0.0001 par value: 1,000,000 and 0 shares authorized at december 31, 2021 and december 31, 2020, respectively; 0 shares issued and outstanding at december 31, 2021 and december 31, 2020, respectively | ||||||||||||||||||||
current contract liabilities | 493,000 | |||||||||||||||||||
series a-1 redeemable convertible preferred stock, 0.00001 par value: 0 and 55,399,943 shares authorized, issued and outstanding at september 30, 2021 and december 31, 2020, respectively; aggregate liquidation preference of 0 and 55,000 at september 30, 2021 and december 31, 2020, respectively | ||||||||||||||||||||
series a-2 redeemable convertible preferred stock, 0.00001 par value: 0 and 64,718,940 shares authorized at september 30, 2021 and december 31, 2020, respectively; 0 and 49,700,364 shares authorized, issued and outstanding at september 30, 2021 and december 31, 2020, respectively; aggregate liquidation preference of 0 and 49,342 at september 30, 2021 and december 31, 2020, respectively | ||||||||||||||||||||
current assets | ||||||||||||||||||||
cash | 167,959 | 627,415 | ||||||||||||||||||
cash and marketable securities held in trust account | 442,785,910 | 442,774,870 | ||||||||||||||||||
current liabilities | ||||||||||||||||||||
deferred underwriting fee payable | 15,496,250 | 15,496,250 | ||||||||||||||||||
preferred stock, 0.0001 par value... | ||||||||||||||||||||
class b common stock, 0.00001 par value... | 1,107 | 1,107 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | ||||||||||||||||||||
net loss | -17,666,000 | -6,529,000 | 5,438,000 | -8,312,000 | -29,173,000 | -20,239,000 | -25,773,000 | -42,286,000 | -46,719,000 | -60,989,000 | -308,761,000 | -77,581,000 | -85,742,000 | -76,896,000 | -40,427,000 | |||||
adjustments to reconcile net loss to net cash from operating activities: | ||||||||||||||||||||
depreciation and amortization expense | 6,881,000 | 6,474,000 | 6,191,000 | 5,678,000 | 5,558,000 | 5,929,000 | 5,218,000 | 5,248,000 | 6,094,000 | 8,672,000 | 10,332,000 | 8,636,000 | 34,040,000 | 10,502,000 | 8,964,000 | 5,803,000 | 5,795,000 | |||
stock-based compensation expense | 9,780,000 | 10,586,000 | 7,813,000 | 3,983,000 | 2,845,000 | 3,636,000 | 3,108,000 | -451,000 | -912,000 | 430,000 | 108,000 | 48,000 | 422,000 | 1,273,000 | 22,721,000 | 17,559,000 | 36,967,000 | |||
change in fair value of financial liabilities | -1,116,000 | |||||||||||||||||||
provision for excess and obsolete inventory | -17,000 | 29,000 | 43,000 | 28,000 | 69,000 | 40,000 | 279,000 | 1,014,000 | 393,000 | 385,000 | 304,000 | 43,000 | 1,007,000 | |||||||
legal reserves | 4,750,000 | -1,327,000 | ||||||||||||||||||
change in third party payor reserves | -6,297,000 | 3,732,000 | 3,619,000 | 1,395,000 | -130,000 | -329,000 | 1,259,000 | -193,000 | ||||||||||||
impairment loss | 0 | 8,282,000 | 0 | 2,120,000 | ||||||||||||||||
other | 781,000 | 995,000 | 630,000 | 757,000 | 991,000 | 901,000 | 892,000 | 846,000 | ||||||||||||
change in operating assets and liabilities: | ||||||||||||||||||||
accounts receivable | -13,432,000 | -12,910,000 | -1,332,000 | -8,557,000 | 429,000 | -12,721,000 | 2,651,000 | 4,220,000 | -463,000 | 552,000 | 451,000 | 9,723,000 | 36,000 | 3,134,000 | 13,489,000 | -11,132,000 | -5,252,000 | |||
inventory | -3,364,000 | 1,332,000 | 628,000 | -2,032,000 | -454,000 | -477,000 | 1,223,000 | -2,877,000 | 293,000 | 1,168,000 | -1,817,000 | 1,331,000 | 7,589,000 | -2,957,000 | 622,000 | -2,904,000 | -3,290,000 | |||
accounts payable and accrued expenses | 6,915,000 | -2,014,000 | -3,625,000 | 10,824,000 | -12,654,000 | 2,552,000 | -5,626,000 | -4,733,000 | -7,040,000 | -14,514,000 | -10,929,000 | -14,470,000 | 5,902,000 | -7,155,000 | 31,780,000 | 3,932,000 | 21,231,000 | |||
other assets and liabilities | 10,143,000 | 10,721,000 | -12,010,000 | 3,116,000 | 4,918,000 | 4,892,000 | -1,795,000 | -4,293,000 | -1,155,000 | |||||||||||
net cash from operating activities | -3,090,000 | 15,767,000 | 10,420,000 | 10,182,000 | -3,183,000 | -4,395,000 | -4,505,000 | -16,413,000 | -29,858,000 | -41,228,000 | -53,501,000 | -55,560,000 | -64,654,000 | -88,362,000 | -84,645,000 | -81,494,000 | -51,985,000 | |||
capital expenditures | -2,533,000 | -7,452,000 | 1,186,000 | -3,932,000 | -3,065,000 | 1,465,000 | -887,000 | -407,000 | -3,462,000 | 999,000 | -964,000 | -2,166,000 | -2,242,000 | 548,000 | -53,000 | -5,056,000 | ||||
free cash flows | -5,623,000 | 8,315,000 | 11,606,000 | 6,250,000 | -6,248,000 | -2,930,000 | -5,392,000 | -16,820,000 | -33,320,000 | -40,229,000 | -54,465,000 | -66,820,000 | -90,604,000 | -84,097,000 | -81,547,000 | -57,041,000 | ||||
investing activities | ||||||||||||||||||||
acquisition of business, net of cash acquired | 339,000 | 0 | ||||||||||||||||||
consideration on escrow paid for legacy genedx acquisition | ||||||||||||||||||||
purchases of marketable securities | -19,141,000 | -5,765,000 | -13,561,000 | -17,209,000 | -13,577,000 | -23,344,000 | -24,214,000 | -5,167,000 | -3,735,000 | |||||||||||
proceeds from sales of marketable securities | 3,000 | 0 | 0 | 598,000 | ||||||||||||||||
proceeds from maturities of marketable securities | 10,015,000 | 7,250,000 | 12,775,000 | 13,930,000 | 16,105,000 | 16,235,000 | 2,865,000 | 5,855,000 | ||||||||||||
purchases of property and equipment | -4,347,000 | -6,172,000 | -2,369,000 | -6,129,000 | -3,050,000 | -646,000 | -1,352,000 | -443,000 | -2,376,000 | -112,000 | -2,166,000 | -2,242,000 | -1,370,000 | -1,378,000 | -5,056,000 | |||||
proceeds from sales of assets | ||||||||||||||||||||
development of internal-use software assets | 0 | 0 | 1,000 | -462,000 | -672,000 | -2,036,000 | -1,923,000 | -2,535,000 | -2,637,000 | |||||||||||
net cash from investing activities | -11,072,000 | -4,687,000 | -36,350,000 | -9,408,000 | -519,000 | -7,755,000 | -22,701,000 | 843,000 | -4,864,000 | -27,129,000 | -11,271,000 | -462,000 | -2,838,000 | -4,278,000 | -130,297,000 | -3,913,000 | -7,693,000 | |||
financing activities | ||||||||||||||||||||
proceeds from offerings, net of issuance costs | 21,136,000 | 11,802,000 | -128,000 | 13,894,000 | 31,907,000 | 0 | 0 | |||||||||||||
proceeds from issuance of stock pursuant to employee stock purchase plan | ||||||||||||||||||||
exercise of stock options | 1,040,000 | 182,000 | 65,000 | 735,000 | 147,000 | 86,000 | 137,000 | 24,000 | 19,000 | 0 | 0 | 266,000 | 725,000 | 404,000 | 1,117,000 | 702,000 | 276,000 | |||
long-term debt principal payments | -305,000 | -304,000 | -302,000 | -300,000 | -299,000 | 0 | 0 | |||||||||||||
finance lease payoff and principal payments | -611,000 | -1,229,000 | -509,000 | -528,000 | -462,000 | -1,465,000 | ||||||||||||||
proceeds from long-term debt | ||||||||||||||||||||
net cash from financing activities | 23,193,000 | 10,768,000 | 346,000 | 13,718,000 | 31,023,000 | 13,968,000 | -391,000 | -438,000 | 47,103,000 | -911,000 | 7,388,000 | 132,658,000 | 65,000 | -160,000 | -1,029,000 | |||||
net increase in cash, cash equivalents and restricted cash | 9,031,000 | 14,492,000 | -27,597,000 | -16,008,000 | -57,384,000 | 76,636,000 | -60,707,000 | |||||||||||||
cash, cash equivalents and restricted cash, at beginning of year | ||||||||||||||||||||
cash, cash equivalents and restricted cash, at end of year | ||||||||||||||||||||
supplemental disclosures of cash flow information | ||||||||||||||||||||
cash paid for interest | 1,578,000 | 1,625,000 | 1,610,000 | 1,600,000 | 609,000 | 2,035,000 | 2,014,000 | 2,019,000 | 1,925,000 | 170,000 | 363,000 | 583,000 | 586,000 | 607,000 | ||||||
cash paid for taxes | 236,000 | 119,000 | 714,000 | 206,000 | 257,000 | 353,000 | 257,000 | 300,000 | 287,000 | 175,000 | 899,000 | 104,000 | 197,000 | 168,000 | ||||||
purchases of property and equipment in accounts payable and accrued expenses | 1,814,000 | -1,280,000 | 3,555,000 | 2,197,000 | -15,000 | 2,111,000 | 465,000 | 36,000 | -1,086,000 | 1,111,000 | -964,000 | 1,073,000 | 1,918,000 | 1,325,000 | ||||||
stock consideration paid pursuant to exercise of perceptive warrant | 0 | 0 | ||||||||||||||||||
assets acquired under capital leases obligations | 0 | 0 | ||||||||||||||||||
issuance of common stock for first opko milestone payment | ||||||||||||||||||||
lease liability from obtaining right-of-use asset | ||||||||||||||||||||
deferred tax expense | 246,000 | -245,000 | 447,000 | |||||||||||||||||
proceeds from issuance of common stock pursuant to employee stock purchase plan | 0 | |||||||||||||||||||
finance lease principal payments | -912,000 | -175,000 | -609,000 | -660,000 | -998,000 | -772,000 | -862,000 | |||||||||||||
cash, cash equivalents and restricted cash, at beginning of period | 0 | 0 | 86,202,000 | 0 | 0 | 100,668,000 | 0 | 0 | 138,303,000 | 0 | 0 | 401,469,000 | ||||||||
cash, cash equivalents and restricted cash, at end of period | 21,848,000 | -25,584,000 | 100,694,000 | 1,818,000 | -27,597,000 | 84,660,000 | -69,268,000 | -57,384,000 | 214,939,000 | -93,287,000 | -16,885,000 | 315,902,000 | ||||||||
assets acquired under capital lease obligations | ||||||||||||||||||||
net income | 71,481,803 | -58,471,923 | ||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||
change in fair value of warrants and contingent liabilities | 1,980,000 | 880,000 | 4,409,000 | 6,101,000 | ||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | 27,321,000 | 12,381,000 | -93,287,000 | -16,885,000 | -85,567,000 | |||||||||||||||
change in fair value of warrants | 1,100,000 | |||||||||||||||||||
deferred tax benefit | -24,000 | -47,000 | -190,000 | -82,000 | -411,000 | -172,000 | -196,000 | -147,000 | ||||||||||||
gain on sale of assets | 1,277,000 | 0 | ||||||||||||||||||
gain on debt forgiveness | 0 | 0 | 0 | -2,750,000 | ||||||||||||||||
issuance of stock pursuant to employee stock purchase plan | ||||||||||||||||||||
issuance of common stock for first milestone payment | ||||||||||||||||||||
stock consideration paid for purchase of business | ||||||||||||||||||||
consideration on escrow paid for genedx acquisition | 0 | 0 | ||||||||||||||||||
software development costs in accounts payable and accrued expenses | 157,000 | 401,000 | 717,000 | |||||||||||||||||
third-party payor reserve release | ||||||||||||||||||||
change in operating assets and liabilities, net of effects from purchase of business: | ||||||||||||||||||||
proceeds from sale of assets | 147,000 | 253,000 | ||||||||||||||||||
proceeds from pipe issuance, net of issuance costs | ||||||||||||||||||||
proceeds from long-term debt, net of issuance costs | ||||||||||||||||||||
stock consideration paid for first milestone payment | ||||||||||||||||||||
change in fair value of warrant and earn-out contingent liabilities | -591,000 | -3,547,000 | 3,453,000 | -12,978,000 | -28,182,000 | -13,190,000 | ||||||||||||||
third party payor reserve release | -2,540,000 | |||||||||||||||||||
non-cash lease expense | 529,000 | 9,000 | 146,000 | 1,113,000 | 781,000 | 164,000 | 167,000 | 381,000 | ||||||||||||
amortization of deferred debt issuance costs | 130,000 | 129,000 | 128,000 | 130,000 | 129,000 | 128,000 | ||||||||||||||
prepaid expenses and other current assets | 1,244,000 | 4,232,000 | 5,977,000 | 2,243,000 | 1,314,000 | 1,596,000 | 1,460,000 | |||||||||||||
due to/from related parties | -537,000 | 793,000 | 2,252,000 | -610,000 | -1,868,000 | 543,000 | 1,557,000 | |||||||||||||
other assets | 471,000 | -55,000 | 1,353,000 | -229,000 | -975,000 | -151,000 | -1,844,000 | |||||||||||||
contract liabilities | 40,000 | 0 | -65,000 | -408,000 | -20,000 | |||||||||||||||
other current liabilities | 2,142,000 | -7,759,000 | -9,459,000 | -5,201,000 | 1,777,000 | -6,584,000 | 6,614,000 | |||||||||||||
long-term debt principal payment | 0 | -2,000,000 | ||||||||||||||||||
finance lease payoff | 0 | -438,000 | ||||||||||||||||||
unpaid deferred transaction costs included in accounts payable and accrued expenses | 227,000 | |||||||||||||||||||
proceeds from underwritten public offering, net of issuance costs | 135,439,000 | |||||||||||||||||||
change in fair value of warrant and contingent liabilities | -76,230,000 | |||||||||||||||||||
income tax benefit | 52,000 | -99,000 | ||||||||||||||||||
loss on extinguishment of debt | 0 | |||||||||||||||||||
amortization of debt issuance costs | ||||||||||||||||||||
purchase of business, net of cash acquired | 0 | 0 | ||||||||||||||||||
proceeds from issuance of series c redeemable convertible preferred stock, net of issuance costs | ||||||||||||||||||||
proceeds from pipe issuance | 0 | |||||||||||||||||||
proceeds from equity infusion from the merger, net of redemptions | 0 | |||||||||||||||||||
legacy sema4 shareholder payout | 0 | |||||||||||||||||||
payment of transaction costs | 0 | |||||||||||||||||||
stock appreciation rights payout | 0 | |||||||||||||||||||
repayment of long-term debt | 0 | |||||||||||||||||||
debt issuance costs | ||||||||||||||||||||
debt issuance costs incurred but unpaid | ||||||||||||||||||||
loss on debt extinguishment | ||||||||||||||||||||
proceeds from business combination pipe investment | ||||||||||||||||||||
proceeds from acquisition pipe investment, net of issuance costs | ||||||||||||||||||||
payment of deferred transaction costs | ||||||||||||||||||||
net cash from (used) in financing activities | ||||||||||||||||||||
proceeds from issuance of series b redeemable convertible preferred stock, net of issuance costs | ||||||||||||||||||||
capital contributions from ismms | ||||||||||||||||||||
capital lease principal payments | -768,000 | |||||||||||||||||||
class a redeemable common stock | ||||||||||||||||||||
numerator: earnings allocable to class a redeemable common stock | ||||||||||||||||||||
interest income | 121 | 10,919 | ||||||||||||||||||
less: income and franchise tax available to be withdrawn from the trust account | ||||||||||||||||||||
redeemable net earnings | ||||||||||||||||||||
denominator: weighted-average class a redeemable common stock | ||||||||||||||||||||
class a redeemable common stock, basic and diluted | ||||||||||||||||||||
earnings/basic and diluted class a redeemable common stock | ||||||||||||||||||||
class b non-redeemable common stock, basic | ||||||||||||||||||||
numerator: net income minus net earnings | ||||||||||||||||||||
non-redeemable net earnings, basic | ||||||||||||||||||||
denominator: weighted-average class b non-redeemable common stock, basic | ||||||||||||||||||||
earnings/basic class b non-redeemable common stock | ||||||||||||||||||||
numerator: net income minus net earnings diluted | ||||||||||||||||||||
non-redeemable net income - basic | ||||||||||||||||||||
less: change in fair value of derivative liability | ||||||||||||||||||||
non-redeemable net income – diluted | ||||||||||||||||||||
denominator: weighted-average shares outstanding of class a and class b non-redeemable common stock | ||||||||||||||||||||
diluted weighted-average shares outstanding, class a and class b non-redeemable common stock | ||||||||||||||||||||
diluted net income per share, non-redeemable class a and class b non-redeemable common stock | ||||||||||||||||||||
class a common stock | ||||||||||||||||||||
numerator: earnings allocable to class a common stock | ||||||||||||||||||||
income and franchise tax | -10,919 | |||||||||||||||||||
net earnings | ||||||||||||||||||||
denominator: weighted-average class a common stock | ||||||||||||||||||||
class a common stock, basic and diluted | 44,275,000 | |||||||||||||||||||
earnings/basic and diluted class a common stock | ||||||||||||||||||||
class a and b common stock | ||||||||||||||||||||
denominator: weighted-average class a and b common stock | ||||||||||||||||||||
class a and b common stock, basic and diluted | 11,068,750 | |||||||||||||||||||
loss/basic and diluted class a and b common stock | -5.28 | |||||||||||||||||||
redeemable class a common stock | ||||||||||||||||||||
numerator: earnings allocable to redeemable class a common stock | ||||||||||||||||||||
denominator: weighted-average redeemable class a common stock | ||||||||||||||||||||
redeemable class a common stock, basic and diluted | ||||||||||||||||||||
earnings/basic and diluted redeemable class a common stock | ||||||||||||||||||||
non-redeemable class a and b common stock | ||||||||||||||||||||
numerator: net income minus redeemable net earnings | ||||||||||||||||||||
non-redeemable net income | ||||||||||||||||||||
denominator: weighted-average non-redeemable class a and b common stock | ||||||||||||||||||||
non-redeemable class a and b common stock, basic and diluted | ||||||||||||||||||||
loss/basic and diluted non-redeemable class a and b common stock |